Stay updated on PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial
Sign up to get notified when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.

Latest updates to the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check61 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the detailed description of a Phase 3 clinical trial for PH94B nasal spray aimed at treating social anxiety disorder. The only notable addition is the mention of the revision number, which does not alter the core information.SummaryDifference42%
- Check68 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check111 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.